R. Espinosa-Rosso

Neuropsychiatric Symptoms in Clinically Defined Parkinson's Disease: An Updated Review of Literature

Á. J. Cruz-Gómez, J. González-Rosa, Paloma Macías-García, 2022, Behavioural neurology.

Mutational spectrum of GNAL, THAP1 and TOR1A genes in isolated dystonia: study in a population from Spain and systematic literature review

F. Carrillo, P. Gómez-Garre, S. Jesús, 2020, European journal of neurology.

Lack of validation of variants associated with cervical dystonia risk: A GWAS replication study

Inmaculada Bernal-Bernal, Marta Bonilla-Toribio, F. Carrillo, 2014, Movement disorders : official journal of the Movement Disorder Society.

Neuropsychological and Neuropsychiatric Features of Chronic Migraine Patients during the Interictal Phase

Á. J. Cruz-Gómez, J. González-Rosa, L. Forero, 2023, Journal of clinical medicine.

Subthalamic Beta Activity in Parkinson's Disease May Be Linked to Dorsal Striatum Gray Matter Volume and Prefrontal Cortical Thickness: A Pilot Study

Á. J. Cruz-Gómez, J. González-Rosa, Raúl Rashid-López, 2022, Frontiers in Neurology.

Sneddon syndrome presenting with unilateral third cranial nerve palsy.

R. Espinosa-Rosso, D. Jiménez-Gallo, M. Linares‐Barrios, 2014, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

Cortical Thickness and Serum NfL Explain Cognitive Dysfunction in Newly Diagnosed Patients With Multiple Sclerosis

Á. J. Cruz-Gómez, J. González-Rosa, L. Forero, 2021, Neurology: Neuroimmunology & Neuroinflammation.

Predicting Neuropsychological Impairment in Relapsing Remitting Multiple Sclerosis: The Role of Clinical Measures, Treatment, and Neuropsychiatry Symptoms.

J. González-Rosa, R. Gutiérrez, Macarena González, 2020, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

Safety and efficacy of intra-arterial bone marrow mononuclear cell transplantation in patients with acute ischaemic stroke in Spain (IBIS trial): a phase 2, randomised, open-label, standard-of-care controlled, multicentre trial

I. Escudero-Martínez, Fernando Mancha, P. Piñero, 2023, The Lancet Neurology.

Potential risk of disease modifying therapies on neoplasm development and coadjutant factors in multiple sclerosis outpatients

J. González-Caballero, R. Espinosa-Rosso, Rosalía Gil-Bernal, 2021, Scientific Reports.

BDNF Val66Met polymorphism in primary adult‐onset dystonia: A case‐control study and meta‐analysis

F. Carrillo, P. Gómez-Garre, S. Jesús, 2014, Movement disorders : official journal of the Movement Disorder Society.

Neuroimaging and serum biomarkers of neurodegeneration and neuroplasticity in Parkinson’s disease patients treated by intermittent theta-burst stimulation over the bilateral primary motor area: a randomized, double-blind, sham-controlled, crossover trial study

Á. J. Cruz-Gómez, J. González-Rosa, C. Méndez-Bértolo, 2023, Frontiers in aging neuroscience.